Evidence map›Paper›PMID 42350809›Full record

ArticleMolecular systems biology2026

ParTIpy: a scalable framework for archetypal analysis and Pareto task inference.

Philipp Sven Lars Schäfer, Leoni Zimmermann, Paul L Burmedi, Avia Walfisch, Noa Goldenberg, Shira Yonassi, Einat Shaer Tamar, Miri Adler, Jovan Tanevski, Ricardo O Ramirez Flores and 1 more

Abstract read
In one paragraph

Article in Molecular systems biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Philipp Sven Lars SchäferInstitute for Computational Biomedicine, Heidelberg University and Heidelberg University Hospital, Heidelberg, Germany.ORCID http://orcid.org/0009-0008-4403-8592
Leoni ZimmermannInstitute for Computational Biomedicine, Heidelberg University and Heidelberg University Hospital, Heidelberg, Germany.ORCID http://orcid.org/0009-0004-9338-4978
Paul L BurmediInstitute for Computational Biomedicine, Heidelberg University and Heidelberg University Hospital, Heidelberg, Germany.ORCID http://orcid.org/0000-0001-8391-0031
Avia WalfischDepartment of Genetics, Silberman Institute of Life Sciences; and Department of Immunology and Cancer Research, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Noa GoldenbergDepartment of Genetics, Silberman Institute of Life Sciences; and Department of Immunology and Cancer Research, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Shira YonassiDepartment of Genetics, Silberman Institute of Life Sciences; and Department of Immunology and Cancer Research, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Einat Shaer TamarDepartment of Genetics, Silberman Institute of Life Sciences; and Department of Immunology and Cancer Research, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.ORCID http://orcid.org/0000-0001-8693-7176
Miri AdlerDepartment of Genetics, Silberman Institute of Life Sciences; and Department of Immunology and Cancer Research, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Jovan TanevskiInstitute for Computational Biomedicine, Heidelberg University and Heidelberg University Hospital, Heidelberg, Germany.ORCID http://orcid.org/0000-0001-7177-1003
Ricardo O Ramirez FloresEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, Cambridgeshire, UK. flores@ebi.ac.uk.ORCID http://orcid.org/0000-0003-0087-371X
Julio Saez-RodriguezInstitute for Computational Biomedicine, Heidelberg University and Heidelberg University Hospital, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-8552-8976

Funding

Carl-Zeiss-Stiftung (CZS) P2022-08-010Deutsche Forschungsgemeinschaft (DFG) INST 35/1597-1 FUGGDeutsche Forschungsgemeinschaft (DFG) INST 35/1803-1 FUGGDeutsche Forschungsgemeinschaft (DFG) INST 35/1804-1 LAGGDeutsche Forschungsgemeinschaft (DFG) SPP 2395
6 · The paper itself

Abstract

Trade-offs between different tasks are pervasive across scales in biological systems. For example, cells cannot perform all possible functions simultaneously; instead they allocate limited resources to specialize in subsets of tasks by activating specific gene expression programs. Pareto Task Inference (ParTI) is a framework for analyzing biological trade-offs grounded in multi-objective optimality. However, existing software for ParTI neither scales to large datasets nor integrates well with standard data analysis workflows. To address this gap, we developed ParTIpy ( https://pypi.org/project/partipy ), an open-source Python package that leverages optimization and coreset methods to scale archetypal analysis, the core algorithm underlying ParTI, to millions of cells. By providing tools to characterize archetypes and comprehensive documentation ( https://partipy.readthedocs.io ), ParTIpy integrates seamlessly into existing analysis workflows, especially for single-cell data. We demonstrate how ParTIpy can be used to study intra-cell-type gene expression variability through the lens of task allocation, offering a principled alternative to methods that impose discrete cell state classifications on inherently continuous variation.

Indexed as

Computational BiologySoftwareAlgorithms

Identifiers

PMID42350809
PMCPMC13433804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.